Glibenclamide Attenuates Blood-Brain Barrier Disruption in Adult Mice after Traumatic Brain Injury

Journal of Neurotrauma

Volumn 34, Issue 4, 2017, Pages 925-933

  Xu, Zhi Ming ^a   Yuan, Fang ^a   Liu, Ying Liang ^a   Ding, Jun ^a   Tian, Heng Li ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

Author keywords

Animal studies; Apoptosis; BBB; TBI

Indexed keywords

BETA TUBULIN; CASPASE 3; GLIBENCLAMIDE; HEMOGLOBIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN C JUN; PROTEIN ZO1; STRESS ACTIVATED PROTEIN KINASE; TIGHT JUNCTION PROTEIN; NEUROPROTECTIVE AGENT;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BEND.3 CELL LINE; BIAXIAL STRETCH INJURY; BLOOD BRAIN BARRIER; C57BL 6 MOUSE; CELL CULTURE; CELL LINE; CONTROLLED CORTICAL IMPACT INJURY; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; EVANS BLUE EXTRAVASATION; EXTRAVASATION; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE PERMEABILITY; MOUSE; NEUROPROTECTION; NONHUMAN; SIGNAL TRANSDUCTION; TISSUE LEVEL; TRAUMATIC BRAIN INJURY; WATER CONTENT; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; PATHOPHYSIOLOGY;

ANIMALS; APOPTOSIS; BLOOD-BRAIN BARRIER; BRAIN INJURIES, TRAUMATIC; DISEASE MODELS, ANIMAL; GLYBURIDE; MALE; MICE; MICE, INBRED C57BL; NEUROPROTECTIVE AGENTS; SIGNAL TRANSDUCTION;

EID: 85012895106     PISSN: 08977151     EISSN: 15579042     Source Type: Journal    
DOI: 10.1089/neu.2016.4491     Document Type: Article

References (47)

1. Andriessen, T. M., Horn, J., Franschman, G., van der Naalt, J., Haitsma, I., Jacobs, B., Steyerberg, E. W., and Vos, P. E. (2011). Epidemiology, severity classification, and outcome of moderate and severe traumatic brain injury: a prospective multicenter study. J. Neurotrauma 28, 2019-2031.
2. Thal, S. C., Schaible, E. V., Neuhaus, W., Scheffer, D., Brandstetter, M., Engelhard, K., Wunder, C., and Forster, C. Y. (2013). Inhibition of proteasomal glucocorticoid receptor degradation restores dexamethasone-mediated stabilization of the blood-brain barrier after traumatic brain injury. Crit. Care Med. 41, 1305-1315.
3. Marklund, N., Bakshi, A., Castelbuono, D. J., Conte, V., and McIntosh, T. K. (2006). Evaluation of pharmacological treatment strategies in traumatic brain injury. Curr. Pharm. Des. 12, 1645-1680.
4. Narayan, R. K., Michel, M. E., Ansell, B., Baethmann, A., Biegon, A., Bracken, M. B., Bullock, M. R., Choi, S. C., Clifton, G. L., Contant, C. F., Coplin, W. M., Dietrich, W. D., Ghajar, J., Grady, S. M., Grossman, R. G., Hall, E. D., Heetderks, W., Hovda, D. A., Jallo, J., Katz, R. L., Knoller, N., Kochanek, P. M., Maas, A. I., Majde, J., Marion, D. W., Marmarou, A., Marshall, L. F., McIntosh, T. K., Miller, E., Mohberg, N., Muizelaar, J. P., Pitts, L. H., Quinn, P., Riesenfeld, G., Robertson, C. S., Strauss, K. I., Teasdale, G., Temkin, N., Tuma, R., Wade, C., Walker, M. D., Weinrich, M., Whyte, J., Wilberger, J., Young, A. B., and Yurkewicz, L. (2002). Clinical trials in head injury. J. Neurotrauma 19, 503-557.
5. Roberts, I., Yates, D., Sandercock, P., Farrell, B., Wasserberg, J., Lomas, G., Cottingham, R., Svoboda, P., Brayley, N., Mazairac, G., Laloe, V., Munoz-Sanchez, A., Arango, M., Hartzenberg, B., Khamis, H., Yutthakasemsunt, S., Komolafe, E., Olldashi, F., Yadav, Y., Murillo-Cabezas, F., Shakur, H., Edwards, P., and collaborators (2004). Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. Lancet 364, 1321-1328.
6. Marble, A. (1971). Glibenclamide, a new sulphonylurea: whither oral hypoglycaemic agents Drugs 1, 109-115.
7. Ashcroft, F. M. (1996). Mechanisms of the glycaemic effects of sulfonylureas. Horm. Metab. Res. 28, 456-463.
8. Feldman, J. M. (1985). Review of glyburide after one year on the market. Am. J. Med. 79, 102-108.
9. Kramer, W., Muller, G., Girbig, F., Gutjahr, U., Kowalewski, S., Hartz, D., and Summ, H. D. (1995). The molecular interaction of sulfonylureas with beta-cell ATP-sensitive K(+)-channels. Diabetes Res. Clin. Pract. 28, Suppl., S67-80.
10. Panten, U., Schwanstecher, M., and Schwanstecher, C. (1996). Sulfonylurea receptors and mechanism of sulfonylurea action. Exp. Clin. Endocrinol. 104, 1-9.
11. Kurland, D. B., Tosun, C., Pampori, A., Karimy, J. K., Caffes, N. M., Gerzanich, V., and Simard, J. M. (2013). Glibenclamide for the treatment of acute CNS injury. Pharmaceuticals 6, 1287-1303.
12. Pompermayer, K.,Amaral, F. A., Fagundes, C. T.,Vieira, A. T.,Cunha, F. Q., Teixeira, M. M., and Souza, D. G. (2007). Effects of the treatment with glibenclamide, an ATP-sensitive potassium channel blocker, on intestinal ischemia and reperfusion injury. Eur. J. Pharmacol. 556, 215-222.
13. Simard, J. M., Chen, M., Tarasov, K. V., Bhatta, S., Ivanova, S., Melnitchenko, L., Tsymbalyuk, N., West, G. A., and Gerzanich, V. (2006). Newly expressed SUR1-regulated NC(Ca-ATP) channel mediates cerebral edema after ischemic stroke. Nat. Med. 12, 433-440.
14. Simard, J. M., Yurovsky, V., Tsymbalyuk, N., Melnichenko, L., Ivanova, S., and Gerzanich, V. (2009). Protective effect of delayed treatment with low-dose glibenclamide in three models of ischemic stroke. Stroke 40, 604-609.
15. Simard, J. M., Tsymbalyuk, N., Tsymbalyuk, O., Ivanova, S., Yurovsky, V., and Gerzanich, V. (2010). Glibenclamide is superior to decompressive craniectomy in a rat model of malignant stroke. Stroke 41, 531-537.
16. Simard, J. M., Woo, S. K., Tsymbalyuk, N., Voloshyn, O., Yurovsky, V., Ivanova, S., Lee, R., and Gerzanich, V. (2012). Glibenclamide-10-h treatment window in a clinically relevant model of stroke. Transl. Stroke Res. 3, 286-295.
17. Wali, B., Ishrat, T., Atif, F., Hua, F., Stein, D. G., and Sayeed, I. (2012). Glibenclamide administration attenuates infarct volume, hemispheric swelling, and functional impairments following permanent focal cerebral ischemia in rats. Stroke Res. Treat. 2012, 460909.
18. Simard, J. M., Tsymbalyuk, O., Ivanov, A., Ivanova, S., Bhatta, S., Geng, Z., Woo, S. K., and Gerzanich, V. (2007). Endothelial sulfonylurea receptor 1-regulated NC Ca-ATP channels mediate progressive hemorrhagic necrosis following spinal cord injury. J. Clin. Invest. 117, 2105-2113.
19. Simard, J. M., Woo, S. K., Norenberg, M. D., Tosun, C., Chen, Z., Ivanova, S., Tsymbalyuk, O., Bryan, J., Landsman, D., and Gerzanich, V. (2010). Brief suppression of Abcc8 prevents autodestruction of spinal cord after trauma. Science Transl. Med. 2, 28-29.
20. Simard, J. M., Popovich, P. G., Tsymbalyuk, O., and Gerzanich, V. (2012). Spinal cord injury with unilateral versus bilateral primary hemorrhage-effects of glibenclamide. Exp. Neurol. 233, 829-835.
21. Simard, J. M., Tsymbalyuk, O., Keledjian, K., Ivanov, A., Ivanova, S., and Gerzanich, V. (2012). Comparative effects of glibenclamide and riluzole in a rat model of severe cervical spinal cord injury. Exp. Neurol. 233, 566-574.
22. Simard, J. M., Kilbourne, M., Tsymbalyuk, O., Tosun, C., Caridi, J., Ivanova, S., Keledjian, K., Bochicchio, G., and Gerzanich, V. (2009). Key role of sulfonylurea receptor 1 in progressive secondary hemorrhage after brain contusion. J. Neurotrauma 26, 2257-2267.
23. Patel, A. D., Gerzanich, V., Geng, Z., and Simard, J. M. (2010). Glibenclamide reduces hippocampal injury and preserves rapid spatial learning in a model of traumatic brain injury. J. Neuropathol. Exp. Neurol. 69, 1177-1190.
24. Zweckberger, K., Hackenberg, K., Jung, C. S., Hertle, D. N., Kiening, K. L., Unterberg, A. W., and Sakowitz, O. W. (2014). Glibenclamide reduces secondary brain damage after experimental traumatic brain injury. Neuroscience 272, 199-206.
25. Simard, J. M., Geng, Z., Woo, S. K., Ivanova, S., Tosun, C., Melnichenko, L., and Gerzanich, V. (2009). Glibenclamide reduces inflammation, vasogenic edema, and caspase-3 activation after subarachnoid hemorrhage. J. Cereb. Blood Flow Metab. 29, 317-330.
26. Tosun, C., Kurland,D. B.,Mehta, R., Castellani, R. J., deJong, J. L., Kwon, M. S., Woo, S. K., Gerzanich, V., and Simard, J. M. (2013). Inhibition of the Sur1-Trpm4 channel reduces neuroinflammation and cognitive impairment in subarachnoid hemorrhage. Stroke 44, 3522-3528.
27. Tosun, C., Koltz, M. T., Kurland, D. B., Ijaz, H., Gurakar, M., Schwartzbauer, G., Coksaygan, T., Ivanova, S., Gerzanich, V., and Simard, J. M. (2013). The protective effect of glibenclamide in a model of hemorrhagic encephalopathy of prematurity. Brain Sci. 3, 215-238.
28. Zhou, Y., Fathali, N., Lekic, T., Tang, J., and Zhang, J. H. (2009). Glibenclamide improves neurological function in neonatal hypoxiaischemia in rats. Brain Res. 1270, 131-139.
29. Thompson, E. M., Pishko, G. L., Muldoon, L. L., and Neuwelt, E. A. (2013). Inhibition of SUR1 decreases the vascular permeability of cerebral metastases. Neoplasia 15, 535-543.
30. Yenari, M. A., and Han, H. S. (2012). Neuroprotective mechanisms of hypothermia in brain ischaemia. Nat. Rev. Neurosci. 13, 267-278.
31. Jayakumar, A. R., Valdes, V., Tong, X. Y., Shamaladevi, N., Gonzalez, W., and Norenberg, M. D. (2014). Sulfonylurea receptor 1 contributes to the astrocyte swelling and brain edema in acute liver failure. Transl. Stroke Res. 5, 28-37.
32. Woo, S. K., Kwon, M. S., Ivanov, A., Gerzanich, V., and Simard, J. M. (2013). The sulfonylurea receptor 1 (Sur1)-transient receptor potential melastatin 4 (Trpm4) channel. J. Biol. Chem. 288, 3655-3667.
33. Webster, G. D., Rzigalinski, B. A. and Gabler, H. C. (2008). Development of an improved injury device for neural cell cultures. Biomed. Sci. Instrum. 44, 483-488.
34. Ahmed, S. M., Rzigalinski, B. A., Willoughby, K. A., Sitterding, H. A., and Ellis, E. F. (2000). Stretch-induced injury alters mitochondrial membrane potential and cellular ATP in cultured astrocytes and neurons. J. Neurochem. 74, 1951-1960.
35. Yuan, F., Xu, Z. M., Lu, L. Y., Nie, H., Ding, J., Ying, W. H., and Tian, H. L. (2016). SIRT2 inhibition exacerbates neuroinflammation and blood-brain barrier disruption in experimental traumatic brain injury by enhancing NF-kappaB p65 acetylation and activation. J. Neurochem. 136, 581-593.
36. Laird, M. D., Sukumari-Ramesh, S., Swift, A. E., Meiler, S. E., Vender, J. R., and Dhandapani, K. M. (2010). Curcumin attenuates cerebral edema following traumatic brain injury in mice: a possible role for aquaporin-4 J. Neurochem. 113, 637-648.
37. Sinha, K., Das, J., Pal, P. B., and Sil, P. C. (2013). Oxidative stress: the mitochondria-dependent and mitochondria-independent pathways of apoptosis. Arch. Toxicol. 87, 1157-1180.
38. Riddle, M. C. (2003). Editorial: sulfonylureas differ in effects on ischemic preconditioning-is it time to retire glyburide J. Clin. Endocrinol. Metab. 88, 528-530.
39. Kurland, D., Hong, C., Aarabi, B., Gerzanich, V., and Simard, J. M. (2012). Hemorrhagic progression of a contusion after traumatic brain injury: a review. J. Neurotrauma 29, 19-31.
40. Dhanasekaran, D. N., and Reddy, E. P. (2008). JNK signaling in apoptosis. Oncogene 27, 6245-6251.
41. Stark, R. J., Choi, H., Koch, S. R., Fensterheim, B. A., Lamb, F. S., and Sherwood, E. R. (2016). Endothelial cell tolerance to lipopolysaccharide challenge is induced by monophosphoryl lipid A. Clin. Sci. 130, 451-461.
42. Li, Y., Cao, Y., Zeng, Z., Liang, M., Xue, Y., Xi, C., Zhou, M., and Jiang, W. (2015). Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis prevents lipopolysaccharide-induced apoptosis of pulmonary microvascular endothelial cells by inhibiting JNK/NF-kappaB pathways. Sci. Rep. 5, 8209.
43. Chen, L., Wang, J., Wang, B., Yang, J., Gong, Z., Zhao, X., Zhang, C., and Du, K. (2016). MiR-126 inhibits vascular endothelial cell apoptosis through targeting PI3K/Akt signaling. Ann. Hematol. 95, 365-374.
44. Tien, Y. C., Liao, J. C., Chiu, C. S., Huang, T. H., Huang, C. Y., Chang, W. T., and Peng,W. H. (2011). Esculetin ameliorates carbon tetrachloridemediated hepatic apoptosis in rats. Int. J. Mol. Sci. 12, 4053-4067.
45. Abu-Qare, A. W., and Abou-Donia, M. B. (2001). Biomarkers of apoptosis: release of cytochrome c, activation of caspase-3, induction of 8-hydroxy-2'-deoxyguanosine, increased 3-nitrotyrosine, and alteration of p53 gene. J. Toxicol. Environ. Health B Crit. Rev. 4, 313-332.
46. Anuradha, C. V., and Ravikumar, P. (2001). Restoration on tissue antioxidants by fenugreek seeds (Trigonella Foenum Graecum) in alloxan-diabetic rats. Indian J. Physiol. Pharmacol. 45, 408-420.
47. Song, J. S., Lee, H. Y., Lee, E., Hwang, H. J., and Kim, J. H. (2002). Cytotoxicity and apoptosis induction of sodium fluoride in human promyelocytic leukemia (HL-60) cells. Environ. Toxicol. Pharmacol. 11, 85-91.